Advisor Group Holdings, Inc. Exagen Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Exagen Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,000 shares of XGN stock, worth $11,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$11,110
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XGN
# of Institutions
54Shares Held
8.86MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$18.9 Million0.18% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6851KShares$9.46 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$7.99 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA682KShares$7.57 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$5.91 Million0.03% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $181M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...